- CSR Summary Not Available
- NCT00433329
- Primary Citation
- Data Specification Not Available
Trial Information
Generic NameBosentanProduct NameTRACLEER®Therapeutic AreaRespiratory Tract (Lung and Bronchial) DiseasesEnrollment100% Female82%% WhiteN/A
Product ClassEndothelin Receptor AntagonistSponsor Protocol NumberAC-052-419Data PartnerJohnson & JohnsonCondition StudiedPulmonary Arterial HypertensionMean/Median Age (Years)55.5
Supporting Documentation
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available
Additional Information
Please note: Participant-level data is not available for this study. Only the Protocol with Amendments, Statistical Analysis Plan, and Clinical Study Report are available.